Expect Equity LLC Purchases New Position in InfuSystem Holdings, Inc. $INFU

Expect Equity LLC purchased a new stake in shares of InfuSystem Holdings, Inc. (NYSE:INFU) in the second quarter, Holdings Channel.com reports. The firm purchased 184,819 shares of the company’s stock, valued at approximately $1,784,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new stake in shares of InfuSystem in the second quarter worth approximately $15,299,000. Minerva Advisors LLC boosted its position in shares of InfuSystem by 5.2% during the fourth quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock valued at $9,676,000 after buying an additional 52,942 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of InfuSystem by 1.9% during the third quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock valued at $10,113,000 after buying an additional 18,539 shares during the last quarter. Punch & Associates Investment Management Inc. grew its holdings in InfuSystem by 1.6% during the first quarter. Punch & Associates Investment Management Inc. now owns 837,925 shares of the company’s stock worth $7,734,000 after buying an additional 13,175 shares in the last quarter. Finally, Heartland Advisors Inc. bought a new stake in InfuSystem during the second quarter worth $6,755,000. 71.13% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, B. Riley Financial reissued a “buy” rating and issued a $20.00 price target (up from $12.00) on shares of InfuSystem in a research report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $16.67.

InfuSystem Stock Up 0.6%

InfuSystem stock opened at $12.02 on Wednesday. InfuSystem Holdings, Inc. has a fifty-two week low of $7.29 and a fifty-two week high of $12.97. The stock has a market cap of $242.59 million, a PE ratio of 200.37 and a beta of 1.42. The firm’s 50-day simple moving average is $10.30 and its 200 day simple moving average is $9.59. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98.

InfuSystem declared that its Board of Directors has authorized a share repurchase program on Tuesday, May 19th that allows the company to repurchase $20.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 10.2% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.